Tissue Technologies president Kel Cohen says the dressing, which was approved by the U.S. Food and Drug Administration in 2006, now has a manufacturer and marketer.

Treatment group had 142 patients and for drug nasal irrigation and nasal endoscopy dressing after endoscopic sinus surgery.